Get informed when a big investor buys or sells
+ Follow157.27
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
PureTech Health plc (PTCHF) currently reports a P/E ratio of 157.27. That is above the Finance sector average of 14.29. Use the charts on this page to explore PureTech Health plc's P/E ratio history and peer comparisons.
PureTech Health plc's P/E ratio of 157.27 is higher than the Finance sector average of 14.29. That is roughly 1000.8% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/E ratio is a valuation multiple that relates PureTech Health plc's market price to a fundamental measure such as earnings, sales, or book value. At 157.27, PTCHF can look expensive or cheap only in context — versus its own history, growth rate, and Finance peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of 157.27, then check the historical chart for trend and the peer comparison chart for relative positioning. The Finance average is 14.29. From there, open related valuation or income-statement pages for PureTech Health plc, and consider following PTCHF for alerts when major investors trade the stock.
PureTech Health plc is classified in the Finance sector. On P/E ratio, it currently shows 157.27 versus a sector average near 14.29. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Finance are usually more informative than comparing PTCHF with unrelated industries.